SAM
PTLA

Sectoral Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Sectoral Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-606,189
Closed -$14.5M – 76
2019
Q4 		$14.5M Buy
606,189
+59,700
+11% +$1.65M 2.16% 17
2019
Q3 		$14.7M Sell
546,489
-175,067
-24% -$4.91M 2.53% 11
2019
Q2 		$19.6M Buy
721,556
+112,199
+18% +$3.52M 2.34% 12
2019
Q1 		$21.1M Sell
609,357
-214,250
-26% -$6.18M 2.54% 9
2018
Q4 		$16.1M Buy
823,607
+79,000
+11% +$1.62M 2.19% 14
2018
Q3 		$19.8M Sell
744,607
-50,655
-6% -$1.65M 2.11% 13
2018
Q2 		$30M Buy
795,262
+296,850
+60% +$11.4M 3.36% 5
2018
Q1 		$16.3M Sell
498,412
-38,002
-7% -$1.67M 1.78% 23
2017
Q4 		$26.1M Buy
536,414
+30,000
+6% +$1.52M 3.26% 10
2017
Q3 		$27.4M Buy
506,414
+84,271
+20% +$4.95M 3.52% 6
2017
Q2 		$23.7M Sell
422,143
-181,898
-30% -$7.29M 2.59% 16
2017
Q1 		$23.7M Sell
604,041
-815,363
-57% -$26M 2.76% 17
2016
Q4 		$31.9M Buy
1,419,404
+196
+0% +$3.83K 3.53% 9
2016
Q3 		$32.2M Buy
1,419,208
+189,826
+15% +$4.46M 3.16% 10
2016
Q2 		$29M Sell
1,229,382
-363,657
-23% -$8.98M 3% 15
2016
Q1 		$32.5M Buy
+1,593,039
New +$50.5M 1.57% 19
2015
Q4 		– Sell
-1,088,118
Closed -$46.4M – 82
2015
Q3 		$46.4M Sell
1,088,118
-81,012
-7% -$3.91M 2.12% 15
2015
Q2 		$53.3M Buy
1,169,130
+6,400
+0.6% +$257K 2.22% 15
2015
Q1 		$44.1M Buy
1,162,730
+42,351
+4% +$1.45M 1.68% 23
2014
Q4 		$31.7M Sell
1,120,379
-291,971
-21% -$8.12M 1.42% 28
2014
Q3 		$35.7M Buy
1,412,350
+47,198
+3% +$1.24M 1.5% 23
2014
Q2 		$39.8M Buy
1,365,152
+152,907
+13% +$3.7M 1.69% 23
2014
Q1 		$31.4M Buy
1,212,245
+210,431
+21% +$5.62M 1.29% 29
2013
Q4 		$25.8M Buy
1,001,814
+35,028
+4% +$851K 1.11% 28
2013
Q3 		$25.9M Sell
966,786
-167,252
-15% -$3.98M 1.24% 28
2013
Q2 		$27.9M Buy
+1,134,038
New +$22.5M 0.82% 36

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Sectoral Asset Management's PTLA Position: Q1 2020 in Review

Sectoral Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 606,189 shares — an estimated $14.5M sold.

Sectoral Asset Management first reported a position in PTLA in Q2 2013 and held it in 26 quarters. The position peaked at $53.3M in Q2 2015. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Sectoral Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Sectoral Asset Management sold 606,189 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $14.5M.
  • Sectoral Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
  • Sectoral Asset Management's Portola Pharmaceuticals, Inc. position peaked at $53.3M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Sectoral Asset Management's 13F filing for Q1 2020, filed 13 May 2020.